Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2019
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial
Li Li, Liyan Jiang, Yubo Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2020
Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
Kai Zhang, Xiaohua Hong, Zhengbo Song, et al.
Cancer Research
|
November 26, 2020
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Viralkumar Davra, Sushil Kumar, Ke Geng, et al.
Annals of Translational Medicine
|
September 17, 2021
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
Guozhen Yang, Xiaodong Su, Hong Yang, et al.
Nature Immunology
|
November 21, 2025
Pseudokinase STK40 limits T cell exhaustion through COP1-dependent degradation of AP1-family transcription factors
Svetlana Altshuler-Keylin, Nicole Caduff, Isabel E Ishizuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Rui Wang, Chan Gao, Megan Raymond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2019
Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors
Zhijie Wang, Jianchun Duan, Guoqiang Wang, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2021
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
Dan You, Stephen Hillerman, Gregory Locke, et al.
Horticulture Research
|
August 6, 2021
Haplotype-resolved genome assembly and allele-specific gene expression in cultivated ginger
Shi-Ping Cheng, Kai-Hua Jia, Hui Liu, et al.
Nature
|
February 5, 2025
IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour control
Béatrice Bréart, Katherine Williams, Stellanie Krimm, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2019
Combination of Metformin and Gefitinib as First-Line Therapy for Nondiabetic Advanced NSCLC Patients with EGFR Mutations: A Randomized, Double-Blind Phase II Trial
Li Li, Liyan Jiang, Yubo Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2020
Identification of Deleterious <i>NOTCH</i> Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
Kai Zhang, Xiaohua Hong, Zhengbo Song, et al.
Cancer Research
|
November 26, 2020
Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Viralkumar Davra, Sushil Kumar, Ke Geng, et al.
Annals of Translational Medicine
|
September 17, 2021
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
Guozhen Yang, Xiaodong Su, Hong Yang, et al.
Nature Immunology
|
November 21, 2025
Pseudokinase STK40 limits T cell exhaustion through COP1-dependent degradation of AP1-family transcription factors
Svetlana Altshuler-Keylin, Nicole Caduff, Isabel E Ishizuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 2, 2019
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors
Rui Wang, Chan Gao, Megan Raymond, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 18, 2019
Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden as a Predictor of Overall Survival for Patients With NSCLC Treated With PD-(L)1 Inhibitors
Zhijie Wang, Jianchun Duan, Guoqiang Wang, et al.
Journal for Immunotherapy of Cancer
|
January 7, 2021
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
Dan You, Stephen Hillerman, Gregory Locke, et al.
Horticulture Research
|
August 6, 2021
Haplotype-resolved genome assembly and allele-specific gene expression in cultivated ginger
Shi-Ping Cheng, Kai-Hua Jia, Hui Liu, et al.
Nature
|
February 5, 2025
IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour control
Béatrice Bréart, Katherine Williams, Stellanie Krimm, et al.
Page
of 12